V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290003936 | 290002928 | 1.65 | 43 | Palliative (P) | null | 2017-06-03 | IMATINIB | 02 | N | 290020293 | IMATINIB |
| 290003937 | 290002929 | null | 74.8 | Adjuvant (A) | 2015-06-27 | 2015-07-13 | Oxaliplatin + Modified de Gramont | 02 | N | 290020297 | OXALIPLATIN + MDG |
| 290003938 | 290002929 | 1.66 | null | Curative (C) | 2014-01-29 | 2014-02-04 | Capecitabine + Mitomycin | N | null | 290020297 | CAPECITABINE + MITOMYCIN |
| 290003939 | 290002929 | 1.6 | 75 | Palliative (P) | 2017-07-16 | 2017-07-23 | Oxaliplatin + Modified de Gramont | 02 | N | 290020297 | OXALIPLATIN + MDG |
| 290003940 | 290002929 | null | 74 | Neo-adjuvant (N) | 2016-03-25 | 2016-03-25 | Capecitabine + Mitomycin | 02 | null | 290020297 | CAPECITABINE + MITOMYCIN |
| 290003941 | 290008367 | 1.71 | 81.5 | Not known (9) | 2017-04-06 | 2017-07-28 | Imatinib 400mg | N | N | 290020303 | IMATINIB |
| 290003942 | 290002930 | null | null | Curative (C) | 2013-06-07 | 2013-06-25 | Cisplatin 7 day | N | Y | 290020304 | CISPLATIN |
| 290003943 | 290002931 | null | 73.85 | Curative (C) | 2014-11-06 | 2014-12-02 | Capecitabine + Mitomycin | N | N | 290020306 | CAPECITABINE + MITOMYCIN |
| 290003944 | 290002932 | 1.69 | 67.55 | Curative (C) | 2014-02-13 | 2014-03-15 | FLUOROURACIL + MITOMYCIN | N | Y | 290020307 | FLUOROURACIL + MITOMYCIN |
| 290003947 | 290002934 | 1.75 | 57.5 | Curative (C) | 2014-09-04 | 2014-10-01 | FLUOROURACIL + MITOMYCIN | N | Y | 290020312 | FLUOROURACIL + MITOMYCIN |
| 290003948 | 290006385 | 1.7 | 74.6 | Adjuvant (A) | 2016-04-09 | 2016-04-09 | IMATINIB | 02 | N | 290020317 | IMATINIB |
| 290003949 | 290006385 | 1.72 | 97.9 | Palliative (P) | 2013-06-26 | 2013-07-01 | Oxaliplatin + Modified de Gramont | N | N | 290020317 | OXALIPLATIN + MDG |
| 290003950 | 290002935 | 1.48 | 56.8 | Palliative (P) | 2017-03-03 | 2017-06-02 | Oxaliplatin + Modified de Gramont | N | N | 290020320 | OXALIPLATIN + MDG |
| 290003951 | 290002935 | 1.72 | 66.3 | Palliative (P) | 2017-07-03 | 2017-07-03 | Imatinib 400mg | N | N | 290020320 | IMATINIB |
| 290003952 | 290002936 | 1.82 | 74 | Curative (C) | 2017-12-25 | 2017-12-25 | Mitomycin + MdG | N | N | 290020322 | FLUOROURACIL + MITOMYCIN |
| 290003953 | 290002937 | null | null | null | 2017-07-16 | 2017-08-06 | Capecitabine + Mitomycin | N | Y | 290020323 | CAPECITABINE + MITOMYCIN |
| 290003954 | 290002937 | 1.62 | 0 | Curative (C) | 2015-05-10 | 2015-05-24 | Mitomycin + MdG | 02 | Y | 290020323 | FLUOROURACIL + MITOMYCIN |
| 290003955 | 290002938 | null | null | Disease modification (D) | 2013-09-08 | 2013-09-29 | Oxaliplatin + Modified de Gramont | 02 | N | 290020326 | OXALIPLATIN + MDG |
| 290003956 | 290002939 | 1.48 | 63 | Palliative (P) | null | 2017-04-23 | Oxaliplatin + Modified de Gramont | 02 | null | 290020327 | OXALIPLATIN + MDG |
| 290003957 | 290002939 | 1.77 | 80 | null | 2015-04-12 | 2015-05-23 | Carboplatin + Etoposide iv&po | N | N | 290020327 | CARBOPLATIN |
| 290003958 | 290002940 | null | 81.5 | Palliative (P) | 2013-03-13 | 2013-03-20 | CISPLATIN + FLUOROURACIL | N | null | 290020329 | CAPECITABINE |
| 290003959 | 290002941 | null | 58.1 | Palliative (P) | 2017-07-03 | 2017-07-06 | Bevacizumab + Capecitabine | N | N | 290020330 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 290003960 | 290002942 | 1.63 | 77 | Palliative (P) | 2017-10-06 | 2017-10-10 | Fluorouracil 96hr infusion+R(4g/m2) | 02 | N | 290020331 | CAPECITABINE + RT |
| 290003961 | 290002942 | 1.68 | 62.5 | Curative (C) | 2017-12-26 | 2017-12-31 | Capecitabine + Cisplatin | 02 | N | 290020331 | IRINOTECAN + MDG |
| 290003962 | 290002943 | 1.8 | 0 | Not known (9) | 2016-03-15 | 2016-04-18 | Carboplatin + Etoposide IV 3 day | N | N | 290020334 | EOX |
| 290003963 | 290002944 | 1.55 | 66.8 | Palliative (P) | 2012-10-29 | 2013-04-14 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 290020337 | LANREOTIDE |
| 290003964 | 290002945 | 1.86 | 70 | Palliative (P) | 2013-12-09 | 2013-12-09 | PACLITAXEL | 02 | N | 290020338 | CISPLATIN + GEMCITABINE |
| 290003965 | 290002945 | 1.74 | 48 | Adjuvant (A) | 2015-11-08 | 2015-11-21 | Carboplatin AUC 6 - 10 | N | Y | 290020338 | AZACITIDINE |
| 290003966 | 290002945 | 1.6 | 48.5 | Palliative (P) | 2015-05-30 | 2015-06-10 | Fluorouracil 96hr infusion+R(4g/m2) | N | N | 290020338 | FLUOROURACIL |
| 290003967 | 290002946 | 1.71 | 80 | Palliative (P) | 2013-10-07 | 2013-10-29 | ECX | 99 | N | 290020343 | CAPECITABINE + CARBOPLATIN |
| 290003968 | 290002947 | 1.7 | 69.8 | Palliative (P) | 2014-08-04 | 2014-08-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 290020344 | PEMBROLIZUMAB |
| 290003969 | 290002948 | 0 | 73 | Neo-adjuvant (N) | 2013-05-11 | 2013-05-14 | Rituximab | 02 | N | 290020345 | ESPAC TRIAL |
| 290003970 | 290002949 | 1.7 | 53.7 | Palliative (P) | 2013-03-08 | 2013-03-15 | Trial Unspecified | N | N | 290020347 | LANREOTIDE |
| 290003971 | 290002949 | 1.62 | 95 | null | null | 2013-09-18 | CISPLATIN + DOCETAXEL + FLUOROURACIL | Y | Y | 290020347 | CAPECITABINE + RT |
| 290003972 | 290002950 | 1.63 | 66.2 | Palliative (P) | 2015-07-10 | 2015-07-13 | Capecitabine + Streptozocin | 2 | N | 290020349 | CISPLATIN + FLUOROURACIL |
| 290003973 | 290002951 | 1.64 | 0 | Adjuvant (A) | 2015-07-05 | 2015-07-24 | CISPLATIN + FLUOROURACIL | N | N | 290020350 | CARBO + FLUOROURACIL |
| 290003974 | 290002952 | null | 73 | Curative (C) | null | 2016-11-05 | Carbo F | null | null | 290020351 | CAPECITABINE + RT |
| 290003975 | 290006392 | null | null | Palliative (P) | 2013-09-26 | 2013-09-29 | Gemcitabine + Methylprednisolone | 02 | null | 290020352 | EOX |
| 290003976 | 290006392 | 1.7 | 67.2 | Palliative (P) | 2015-10-06 | 2015-10-26 | Bendamustine+Rituximab (1st Course) | N | N | 290020352 | OCTREOTIDE |
| 290003977 | 290002953 | 1.59 | null | Palliative (P) | 2016-10-30 | 2016-10-30 | FLUOROURACIL | 1 | N | 290020354 | LANREOTIDE |
| 290003978 | 290006393 | null | 83.1 | Disease modification (D) | 2016-12-07 | 2016-12-19 | GemCarbo Days 1+8 | 02 | N | 290020355 | CAPECITABINE + RT |
| 290003979 | 290006393 | 1.86 | 116 | Palliative (P) | 2013-11-14 | 2013-11-20 | PLATO Trials | N | N | 290020355 | CARBO + FLUOROURACIL |
| 290003980 | 290002954 | 1.78 | 64.6 | Palliative (P) | null | 2013-12-12 | CETUXIMAB + CISPLATIN + FU | null | null | 290020358 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290003981 | 290002955 | 1.69 | 94.4 | Neo-adjuvant (N) | 2015-10-12 | 2015-11-19 | Capecitabine | N | N | 290020360 | OCTREOTIDE |
| 290003982 | 290002956 | 1.6 | 78 | Neo-adjuvant (N) | 2014-01-12 | 2014-02-12 | Capecitabine 35days + RT | N | N | 290020361 | CISPLATIN + FLUOROURACIL |
| 290003983 | 290002956 | 1.56 | 44.3 | Palliative (P) | 2016-10-26 | 2016-10-26 | CARBOPLATIN + ETOPOSIDE | null | N | 290020361 | GEMCARBO |
| 290003984 | 290002956 | null | null | Neo-adjuvant (N) | 2014-02-26 | 2014-03-01 | Rituximab | N | N | 290020361 | CETUXIMAB |
| 290003985 | 290002956 | 1.6 | 56.9 | Curative (C) | 2017-08-14 | 2017-08-26 | Trial Unspecified | N | null | 290020361 | LANREOTIDE |
| 290003986 | 290002957 | 0 | 68.5 | Neo-adjuvant (N) | 2013-11-14 | 2013-11-14 | Capecitabine | Y | N | 290020369 | CISPLATIN + FLUOROURACIL |
| 290003987 | 290002957 | 1.74 | 90 | Palliative (P) | 2015-01-26 | 2015-01-26 | CARBOPLATIN + ETOPOSIDE | N | N | 290020369 | CAPECITABINE + RT |